Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Liu

Showing results (371-380 of 574) with videos related to

Pageof 58
Sort By:
Cancer Medicine|August 28, 2024
On the informative value of community-based indoor radon values in relation to lung cancerAlbert Rosenberger, Heike Bickeböller, David C Christiani, et al.
Future Oncology (London, England)|October 3, 2024
Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancerBenjamin J Solomon, Geoffrey Liu, Enriqueta Felip, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2024
Lorlatinib Versus Crizotinib in Patients With Advanced <i>ALK</i>-Positive Non-Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN StudyBenjamin J Solomon, Geoffrey Liu, Enriqueta Felip, et al.
Cancer Treatment and Research Communications|November 18, 2023
Presentation and outcomes of KRAS<sup>G12C</sup> mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrenceNiki Esfahanian, Sze Wah Samuel Chan, Luna J Zhan, et al.
Journal of Oncology Practice|June 11, 2015
Lifestyle Behaviors in Elderly Cancer Survivors: A Comparison With Middle-Age Cancer SurvivorsChongya Niu, Lawson Eng, Xin Qiu, et al.
Cancer Medicine|January 12, 2017
Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survivalOlusola O Faluyi, Lawson Eng, Xin Qiu, et al.
Cancer|January 19, 2023
Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosisJohn J W Lee, Vijay Kunaratnam, Christina J H Kim, et al.
Advances in Radiation Oncology|June 13, 2020
Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain MetastasesMatthew Ramotar, Sierra Barnes, Fabio Moraes, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 13, 2013
Primary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftmentLorin Dodbiba, Jennifer Teichman, Andrew Fleet, et al.
Cancer Medicine|October 26, 2019
Real-world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non-small cell lung cancerShirley Xue Jiang, Ryan N Walton, Katrina Hueniken, et al.
Pageof 58

Showing results (371-380 of 574) with videos related to

Sort By:
Pageof 58
Cancer Medicine|August 28, 2024
On the informative value of community-based indoor radon values in relation to lung cancerAlbert Rosenberger, Heike Bickeböller, David C Christiani, et al.
Future Oncology (London, England)|October 3, 2024
Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancerBenjamin J Solomon, Geoffrey Liu, Enriqueta Felip, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2024
Lorlatinib Versus Crizotinib in Patients With Advanced <i>ALK</i>-Positive Non-Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN StudyBenjamin J Solomon, Geoffrey Liu, Enriqueta Felip, et al.
Cancer Treatment and Research Communications|November 18, 2023
Presentation and outcomes of KRAS<sup>G12C</sup> mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrenceNiki Esfahanian, Sze Wah Samuel Chan, Luna J Zhan, et al.
Journal of Oncology Practice|June 11, 2015
Lifestyle Behaviors in Elderly Cancer Survivors: A Comparison With Middle-Age Cancer SurvivorsChongya Niu, Lawson Eng, Xin Qiu, et al.
Cancer Medicine|January 12, 2017
Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survivalOlusola O Faluyi, Lawson Eng, Xin Qiu, et al.
Cancer|January 19, 2023
Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosisJohn J W Lee, Vijay Kunaratnam, Christina J H Kim, et al.
Advances in Radiation Oncology|June 13, 2020
Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain MetastasesMatthew Ramotar, Sierra Barnes, Fabio Moraes, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 13, 2013
Primary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftmentLorin Dodbiba, Jennifer Teichman, Andrew Fleet, et al.
Cancer Medicine|October 26, 2019
Real-world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non-small cell lung cancerShirley Xue Jiang, Ryan N Walton, Katrina Hueniken, et al.
Pageof 58